Correlation Between Lipocine and Brazil Potash
Can any of the company-specific risk be diversified away by investing in both Lipocine and Brazil Potash at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and Brazil Potash into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipocine and Brazil Potash Corp, you can compare the effects of market volatilities on Lipocine and Brazil Potash and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of Brazil Potash. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and Brazil Potash.
Diversification Opportunities for Lipocine and Brazil Potash
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Lipocine and Brazil is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and Brazil Potash Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brazil Potash Corp and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with Brazil Potash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brazil Potash Corp has no effect on the direction of Lipocine i.e., Lipocine and Brazil Potash go up and down completely randomly.
Pair Corralation between Lipocine and Brazil Potash
Given the investment horizon of 90 days Lipocine is expected to generate 0.8 times more return on investment than Brazil Potash. However, Lipocine is 1.25 times less risky than Brazil Potash. It trades about -0.02 of its potential returns per unit of risk. Brazil Potash Corp is currently generating about -0.44 per unit of risk. If you would invest 521.00 in Lipocine on September 15, 2024 and sell it today you would lose (19.00) from holding Lipocine or give up 3.65% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 57.14% |
Values | Daily Returns |
Lipocine vs. Brazil Potash Corp
Performance |
Timeline |
Lipocine |
Brazil Potash Corp |
Lipocine and Brazil Potash Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lipocine and Brazil Potash
The main advantage of trading using opposite Lipocine and Brazil Potash positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, Brazil Potash can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brazil Potash will offset losses from the drop in Brazil Potash's long position.Lipocine vs. Emergent Biosolutions | Lipocine vs. Bausch Health Companies | Lipocine vs. Neurocrine Biosciences | Lipocine vs. Teva Pharma Industries |
Brazil Potash vs. Asure Software | Brazil Potash vs. Verde Clean Fuels | Brazil Potash vs. Rackspace Technology | Brazil Potash vs. Lipocine |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |